Join the UTSW Brainiacs for the 2014 Greater Dallas Walk to End Alzheimer's
Register now to join the Brainiacs or make a donation.
Lectures now online from ADC Symposium 2014
Thank you to the Winspear Family Center for Research on the Neuropathology of Alzheimer's Disease and their generous support for making it possible for the Alzheimer's Disease Center at UT Southwestern to provide the lectures online.
Learn how the excellent staff and physicians at the ADC helped a Dallas couple prepare for a future with Alzheimer's.
Dr. Mary Quiceno is interviewed on WFAA for a story about a former North Texas basketball coach now living with Alzheimer's
Dr. Roger Rosenberg answers that question and many others about the progress of research into a preventative treatment for Alzheimer's. Listen in as Dr. Rosenberg talks with host Krys Boyd on the KERA program, Think.
"The symposium was a great step forward to raise awareness on our campus about neurodegenerative disease research, and especially research on Alzheimer’s disease, and to demonstrate definitively that in-depth research in these areas is alive and well at UT Southwestern and that it is a great time for trainees and faculty, junior and senior, to get involved." - Roger Rosenberg, M.D., Director, Alzheimer's Disease Center
The National Institute on Aging of the National Institutes of Health has renewed the Alzheimer’s Disease Center (ADC) grant for another five years. The NIH grant award is for $9 million and is the fifth consecutive grant renewal for the ADC dating back to 1988. “We look forward to a highly productive and exciting five years ahead of renewed funding for our research,” said Roger N. Rosenberg, M.D., Director of the ADC.
The Friends of the Alzheimer’s Disease Center hosted a public forum on Wednesday, March 23. Steven McKnight, Ph.D., chairman of UT Southwestern Medical Center’s Department of Biochemistry talked about a small molecule that he and his colleagues discovered that can boost learning and memory, as well as prevent new brain cells from dying. They are working to “polish” this early-stage drug lead so that it might help patients suffering from various neurodegenerative diseases, such as Alzheimer’s Disease. Andrew Pieper, M.D., Ph.D., one of Dr. McKnight’s co-investigators, partners with him in the presentation.
DALLAS - Apr 21, 2011 - Mary Quiceno, M.D., has been awarded a grant from the Southwestern Aging and Geriatric Education (SAGE) program.